SECsense Logo

Eton Pharmaceuticals 8-K Report: Key Updates from December 19, 2024

$ETON
Form 8-K
Filed on: 2024-12-20
Source
Eton Pharmaceuticals 8-K Report: Key Updates from December 19, 2024

Based on the provided XML section of the financial report, here are the key pieces of information and insights extracted:

  1. Company Information:
  • Name: Eton Pharmaceuticals, Inc.
  • CIK: 0001710340
  • IRS Employer Identification Number: 37-1858472
  • Address: 21925 W. Field Parkway, Suite 235, Deer Park, IL 60010
  • Contact Number: 847-787-7361
  1. Filings and Reporting:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes that are important to shareholders)
  • Filing Date: December 19, 2024
  1. Business Identifier:
  • Common Stock Symbol: ETON
  • Exchange: NASDAQ
  1. Period of Report:
  • The report covers a single day: December 19, 2024.
  1. XBRL Information:
  • The document adheres to the XBRL (eXtensible Business Reporting Language) standard, which is often used for the electronic communication of business and financial data.

Insights:

  • The filing is an 8-K, indicating that there may be significant news or events disclosed that could impact investors.
  • The report is specific to a single day, which may suggest the announcement of a specific event or decision that occurred on that date.
  • Eton Pharmaceuticals is listed on NASDAQ, which may provide insights into its market performance and investor interest.

Overall, while the information is limited, it highlights the importance of monitoring Eton Pharmaceuticals for any developments that could affect its stock performance and investor relations.